Literature DB >> 17410451

Helicobacter pylori infection and severity of reflux-induced esophageal disease in a cohort of patients with columnar-lined esophagus.

James R Ramus1, Piers A C Gatenby, Christine P J Caygill, Anthony Watson.   

Abstract

The relationship between Helicobacter pylori infection and reflux-induced esophageal diseased is controversial. We examined esophageal disease severity in patients with columnar-lined esophagus and compared results between patients with and without Helicobacter pylori infection. Medical records of 1000 patients diagnosed with columnar-lined esophagus were examined. Endoscopic and histological findings of reflux-induced esophageal disease were compared between H. pylori-positive and H. pylori-negative patients. Four hundred twenty-nine patients (42.9%) showed evidence of H. pylori status, of whom 239 (55.7%) were positive and 190 (44.3%) negative. There were no significant differences in length of columnar-lined segment (P = 0.305), frequency of associated esophagitis (P = 0.583), or presence of gastroduodenal inflammation (P = 0.335, P = 0.131) between the two groups. Histological grade of esophageal disease severity was similar between them, with no statistically significant differences (P = 0.231). We conclude that in patients with established columnar-lined esophagus, there appears to be no difference in severity of reflux-induced esophageal disease between those with and those without H. pylori infection.

Entities:  

Mesh:

Year:  2007        PMID: 17410451     DOI: 10.1007/s10620-006-9706-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  H pylori: the bug is not all bad.

Authors:  J E Richter
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

3.  Barrett's esophagus and the presence of Helicobacter pylori.

Authors:  R D Henihan; R C Stuart; N Nolan; T F Gorey; T P Hennessy; C A O'Morain
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

4.  Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus.

Authors:  M Newton; R Bryan; W R Burnham; M A Kamm
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

5.  Campylobacter pylori and duodenal ulcers: the gastrin link.

Authors:  S Levi; K Beardshall; G Haddad; R Playford; P Ghosh; J Calam
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

6.  The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying.

Authors:  S M Fink; K W Barwick; V DeLuca; F J Sanders; M Kandathil; R W McCallum
Journal:  J Clin Gastroenterol       Date:  1984-08       Impact factor: 3.062

Review 7.  Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?

Authors:  J M Lee; C A O'Morain
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

8.  Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.

Authors:  J Labenz; B Tillenburg; U Peitz; J P Idström; E F Verdú; M Stolte; G Börsch; A L Blum
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

9.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

Authors:  E M el-Omar; I D Penman; J E Ardill; R S Chittajallu; C Howie; K E McColl
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

10.  Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus.

Authors:  R J Loffeld; B J Ten Tije; J W Arends
Journal:  Am J Gastroenterol       Date:  1992-11       Impact factor: 10.864

View more
  1 in total

1.  Effect of Helicobacter pylori eradication on reflux esophagitis therapy: a multi-center randomized control study.

Authors:  Yan Xue; Li-Ya Zhou; San-Ren Lin; Xiao-Hua Hou; Zhao-Shen Li; Min-Hu Chen; Xiu-E Yan; Ling-Mei Meng; Jing Zhang; Jing-Jing Lu
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.